Different levels of p38 MAP kinase activity mediate distinct biological effects in primary human erythroid progenitors

British Journal of Haematology

Volumn 120, Issue 5, 2003, Pages 876-886

  Somervaille, Tim C P ^a   Linch, David C ^a   Khwaja, Asim ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Apoptosis; Differentiation; E cadherin; Erythroblasts; p38 MAP kinase

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; CASPASE; CD36 ANTIGEN; ERYTHROPOIETIN; GLYCOPHORIN A; HEMOGLOBIN A; ISOENZYME; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; MITOGEN ACTIVATED PROTEIN KINASE P38; STEM CELL FACTOR; UNCLASSIFIED DRUG; UVOMORULIN;

APOPTOSIS; ARTICLE; BURST FORMING UNIT; CELL CULTURE; CELL DIFFERENTIATION; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVITY; ERYTHROBLAST; ERYTHROID PRECURSOR CELL; ERYTHROPOIESIS; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANTIGENS, CD36; APOPTOSIS; CADHERINS; CELL DIFFERENTIATION; CELL DIVISION; CELL LINEAGE; CELL MOVEMENT; CELLS, CULTURED; CHROMONES; ENZYME ACTIVATION; ENZYME INHIBITORS; ERYTHROID PROGENITOR CELLS; GLYCOPHORIN; GROWTH SUBSTANCES; HEMOGLOBIN A; HUMANS; MITOGEN-ACTIVATED PROTEIN KINASES; MORPHOLINES; P38 MITOGEN-ACTIVATED PROTEIN KINASES; UP-REGULATION;

EID: 0037337444     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.2003.04204.x     Document Type: Article

References (41)

1. Aiuti, A., Webb, I.J., Bleul, C., Springer, T. & Gutierrez-Ramos, J.C. (1997) The chemokine SDF-1 is a chemoattractant for human CD34+ hematopoietic progenitor cells and provides a new mechanism to explain the mobilization of CD34+ progenitors to peripheral blood. Journal of Experimental Medicine, 185, 111-120.
2. Ayala, J.M., Goyal, S., Liverton, N.J., Claremon, D.A., O'Keefe, S.J. & Hanlon, W.A. (2000) Serum-induced monocyte differentiation and monocyte chemotaxis are regulated by the p38 MAP kinase signal transduction pathway. Journal of Leukocyte Biology, 67, 869-875.
3. Beavon, I.R. (2000) The E-cadherin-catenin complex in tumour metastasis: structure, function and regulation. European Journal of Cancer, 36, 1607-1620.
4. Birkenkamp, K.U., Dokter, W.H., Esselink, M.T., Jonk, L.J., Kruijer, W. & Vellenga, E. (1999) A dual function for p38 MAP kinase in hematopoietic cells: involvement in apoptosis and cell activation. Leukemia, 13, 1037-1045.
5. Buhring, H.J., Muller, T., Herbst, R., Cole, S., Rappold, I., Schuller, W., Zhu, X., Fritzsch, U., Faul, C., Armeanu, S., Ullrich, A., Klein, G. & Schmidt, H. (1996) The adhesion molecule E-cadherin and a surface antigen recognized by the antibody 9C4 are selectively expressed on erythroid cells of defined maturational stages. Leukemia, 10, 106-116.
6. Chen, C.Y. & Shyu, A.B. (1995) AU-rich elements: characterization and importance in mRNA degradation. Trends in Biochemical Sciences, 20, 465-470.
7. Cuenda, A., Rouse, J., Doza, Y.N., Meier, R., Cohen, P., Gallagher, T.F., Young, P.R. & Lee, J.C. (1995) SB203580 is a specific inhibitor of a MAP kinase homologue which is stimulated by cellular stresses and interleukin-1. FEBS Letters, 364, 229-233.
8. Davies, S.P., Reddy, H., Caivano, M. & Cohen, P. (2000) Specificity and mechanism of action of some commonly used protein kinase inhibitors. Biochemical Journal, 351, 95-105.
9. Ellinger-Ziegelbauer, H., Kelly, K. & Siebenlist, U. (1999) Cell cycle arrest and reversion of Ras-induced transformation by a conditionally activated form of mitogen-activated protein kinase 3. Molecular and Cellular Biology, 19, 3857-3868.
10. Ghatan, S., Larner, S., Kinoshita, Y., Hetman, M., Patel, L., Xia, Z., Youle, R.J. & Morrison, R.S. (2000) p38 MAP kinase mediates bax translocation in nitric oxide-induced apoptosis in neurons. Journal of Cell Biology, 150, 335-347.
11. Han, J., Lee, J.D., Bibbs, L. & Ulevitch, R.J. (1994) A MAP kinase targeted by endotoxin and hyperosmolarity in mammalian cells. Science, 265, 808-811.
12. Han, J., Hajjar, D.P., Febbraio, M. & Nicholson, A.C. (1997) Native and modified low density lipoproteins increase the functional expression of the macrophage class B scavenger receptor, CD36. Journal of Biological Chemistry, 272, 21654-21659.
13. Harper, S.J. & LoGrasso, P. (2001) Signalling for survival and death in neurones: the role of stress-activated kinases, JNK and p38. Cell Signaling, 13, 299-310.
14. Ihle, J.N. (2000) The challenges of translating knockout phenotypes into gene function. Cell, 102, 131-134.
15. Jacobs-Helber, S.M., Ryan, J.J. & Sawyer, S.T. (2000) JNK and p38 are activated by erythropoietin (EPO) but are not induced in apoptosis following EPO withdrawal in EPO-dependent HCD57 cells. Blood, 96, 933-940.
16. Kampen, G.T., Stafford, S., Adachi, T., Jinquan, T., Quan, S., Grant, J.A., Skov, P.S., Poulsen, L.K. & Alam, R. (2000) Eotaxin induces degranulation and chemotaxis of eosinophils through the activation of ERK2 and p38 mitogen-activated protein kinases. Blood, 95, 1911-1917.
17. Khwaja, A. & Tatton, L. (1999) Caspase-mediated proteolysis and activation of protein kinase C (delta) plays a central role in neutrophil apoptosis. Blood, 94, 291-301.
18. Lavoie, J.N., L'Allemain, G., Brunet, A., Muller, R. & Pouyssegur, J. (1996) Cyclin D1 expression is regulated positively by the p42/p44MAPK and negatively by the p38/HOGMAPK pathway. Journal of Biological Chemistry, 271, 20608-20616.
19. Lee, J.C., Laydon, J.T., McDonnell, P.C., Gallagher, T.F., Kumar, S., Green, D., McNulty, D., Blumenthal, M.J., Heys, J.R. & Landvatter, S.W. (1994) A protein kinase involved in the regulation of inflammatory cytokine biosynthesis. Nature, 372, 739-746.
20. Lee, J.C., Kumar, S., Griswold, D.E., Underwood, D.C., Votta, B.J. & Adams, J.L. (2000) Inhibition of p38 MAP kinase as a therapeutic strategy. Immunopharmacology, 47, 185-201.
21. Martin-Blanco, E. (2000) p38 MAPK signalling cascades: ancient roles and new functions. Bioessays, 22, 637-645.
22. Nagata, Y. & Todokoro, K. (1999) Requirement of activation of JNK and p38 for environmental stress-induced erythroid differentiation and apoptosis and of inhibition of ERK for apoptosis. Blood, 94, 853-863.
23. Nagata, Y., Moriguchi, T., Nishida, E. & Todokoro, K. (1997) Activation of p38 MAP kinase pathway by erythropoietin and interleukin-3. Blood, 90, 929-934.
24. Nagata, Y., Takahashi, N., Davis, R.J. & Todokoro, K. (1998) Activation of p38 MAP kinase and JNK but not ERK is required for erythropoietin-induced erythroid differentiation. Blood, 92, 1859-1869.
25. Nakahata, T. & Okumura, N. (1994) Cell surface antigen expression in human erythroid progenitors: erythroid and megakaryocytic markers. Leukemia and Lymphoma, 13, 401-409.
26. Nebreda, A.R. & Porras, A. (2000) p38 MAP kinases: beyond the stress response. Trends in Biochemical Sciences, 25, 257-260.
27. Ogura, M. & Kitamura, M. (1998) Oxidant stress incites spreading of macrophages via extracellular signal-regulated kinases and p38 mitogen-activated protein kinase. Journal of Immunology, 161, 3569-3574.
28. Ono, K. & Han, J. (2000) The p38 signal transduction pathway: activation and function. Cell Signaling, 12, 1-13.
29. Petitfrere, E., Kadri, Z., Boudot, C., Sowa, M.L., Mayeux, P., Haye, B. & Billat, C. (2000) Involvement of the p38 mitogen-activated protein kinase pathway in tissue inhibitor of metalloproteinases-1-induced erythroid differentiation. FEBS Letters, 485, 117-121.
30. Rahuel, C., Elouet, J.F. & Cartron, J.P. (1994) Post-transcriptional regulation of the cell surface expression of glycophorins A, B, and E. Journal of Biological Chemistry, 269, 32752-32758.
31. Raingeaud, J., Gupta, S., Rogers, J.S., Dickens, M., Han, J., Ulevitch, R.J. & Davis, R.J. (1995) Pro-inflammatory cytokines and environmental stress cause p38 mitogen-activated protein kinase activation by dual phosphorylation on tyrosine and threonine. Journal of Biological Chemistry, 270, 7420-7426.
32. Somervaille, T.C.P., Linch, D.C. & Khwaja, A. (2001) Growth factor withdrawal from primary human erythroid progenitors induces apoptosis through a pathway involving glycogen synthase kinase-3 and Bax. Blood, 98, 1374-1381.
33. Sundstrom, M., Alfredsson, J., Olsson, N. & Nilsson, G. (2001) Stem cell factor-induced migration of mast cells requires p38 mitogen-activated protein kinase activity. Experimental Cell Research, 267, 144-151.
34. Tibbles, L.A. & Woodgett, J.R. (1999) The stress-activated protein kinase pathways. Cellular and Molecular Life Sciences, 55, 1230-1254.
35. Tong, L., Pav, S., White, D.M., Rogers, S., Crane, K.M., Cywin, C.L., Brown, M.L. & Pargellis, C.A. (1997) A highly specific inhibitor of human p38 MAP kinase binds in the ATP pocket. Nature Structural Biology, 4, 311-316.
36. Volloch, V. & Housman, D. (1981) Stability of globin mRNA in terminally differentiating murine erythroleukemia cells. Cell, 23, 509-514.
37. Winzen, R., Kracht, M., Ritter, B., Wilhelm, A., Chen, C.Y., Shyu, A.B., Muller, M., Gaestel, M., Resch, K. & Holtmann, H. (1999) The p38 MAP kinase pathway signals for cytokine-induced mRNA stabilization via MAP kinase-activated protein kinase 2 and an AU-rich region-targeted mechanism. EMBO Journal, 18, 4969-4980.
38. Witt, O., Sand, K. & Pekrun, A. (2000) Butyrate-induced erythroid differentiation of human K562 leukemia cells involves inhibition of ERK and activation of p38 MAP kinase pathways. Blood, 95, 2391-2396.
39. de Wynter, E.A., Heyworth, C.M., Mukaida, N., Jaworska, E., Weffort-Santos, A., Matushima, K. & Testa, N.G. (2001) CCR1 chemokine receptor expression isolates erythroid from granulocyte-macrophage progenitors. Journal of Leukocyte Biology, 70, 455-460.
40. Zechner, D., Craig, R., Hanford, D.S., McDonough, P.M., Sabbadini, R.A. & Glembotski, C.C. (1998) MKK6 activates myocardial cell NF-kappaB and inhibits apoptosis in a p38 mitogen-activated protein kinase-dependent manner. Journal of Biological Chemistry, 273, 8232-8239.
41. Zu, Y.L., Qi, J., Gilchrist, A., Fernandez, G.A., Vazquez-Abad, D., Kreutzer, D.L., Huang, C.K. & Sha'afi, R.I. (1998) p38 mitogen-activated protein kinase activation is required for human neutrophil function triggered by TNF-alpha or FMLP stimulation. Journal of Immunology, 160, 1982-1989.